Skip to main content
Erschienen in: Quality of Life Research 10/2013

01.12.2013

Comparison of direct-measured and derived short form six dimensions (SF-6D) health preference values among chronic hepatitis B patients

verfasst von: Carlos K. H. Wong, Elegance T. P. Lam, Cindy L. K. Lam

Erschienen in: Quality of Life Research | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The short form six dimensions (SF-6D) are derived from the SF-36 Health Survey with the intention that item data of the latter are often converted to a preference value, which was subsequently used in economic evaluations of interventions. The aim was to compare the equivalence and sensitivity of health preference values derived from the SF-36/SF-12 Health Surveys to that measured directly by the SF-6D for chronic hepatitis B (CHB) patients.

Methods

This was a secondary analysis of the SF-6D and SF-36 data from a baseline sample of 589 patients with CHB infection with different stages of liver diseases. Degree of agreement (equivalence) between direct-measured and derived SF-6D values was determined using spearman correlation and intra-class correlation. Sensitivity and discriminative power of different SF-6D values were compared by standardized effect size and relative efficiency (RE) statistics.

Results

Significant differences in the direct-measured or derived SF-6D preference values were found between CHB groups. Degree of agreement between SF-6D values was satisfactory. Direct-measured SF-6D was the most efficient, followed by SF-12-derived and the SF-36-derived was the least, based on the standardized effect size and the RE statistics. Sensitivity and discriminative power of direct-measured SF-6D were superior to derived SF-6D among people with different CHB health states.

Conclusions

Although direct-measured and derived SF-6D preference values had satisfactory sensitivity in discriminating between CHB groups, direct-measured SF-6D is the most sensitive and preferable method of obtaining health preference.
Literatur
1.
Zurück zum Zitat World Health Organization. (1996). World health report 1996: Fighting disease, fostering development. Geneva: World Health Organization.CrossRef World Health Organization. (1996). World health report 1996: Fighting disease, fostering development. Geneva: World Health Organization.CrossRef
2.
Zurück zum Zitat Lam, E. T. P., Lam, C. L. K., Lai, C. L., Yuen, M. F., Fong, D. Y. T., & So, T. (2009). Health-related quality of life of southern Chinese with chronic hepatitis B infection. Health and Quality of Life Outcomes, 7(1), 52.PubMedCrossRef Lam, E. T. P., Lam, C. L. K., Lai, C. L., Yuen, M. F., Fong, D. Y. T., & So, T. (2009). Health-related quality of life of southern Chinese with chronic hepatitis B infection. Health and Quality of Life Outcomes, 7(1), 52.PubMedCrossRef
3.
Zurück zum Zitat Levy, A. R., Kowdley, K. V., Iloeje, U., Tafesse, E., Mukherjee, J., Gish, R., et al. (2008). The impact of chronic hepatitis B on quality of life: A multinational study of utilities from infected and uninfected persons. Value in Health, 11(3), 527–538.PubMedCrossRef Levy, A. R., Kowdley, K. V., Iloeje, U., Tafesse, E., Mukherjee, J., Gish, R., et al. (2008). The impact of chronic hepatitis B on quality of life: A multinational study of utilities from infected and uninfected persons. Value in Health, 11(3), 527–538.PubMedCrossRef
4.
Zurück zum Zitat Dan, A. A., Kallman, J. B., Srivastava, R., Younoszai, Z., Kim, A., & Younossi, Z. M. (2008). Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index. Liver Transplantation, 14(3), 321–326.PubMedCrossRef Dan, A. A., Kallman, J. B., Srivastava, R., Younoszai, Z., Kim, A., & Younossi, Z. M. (2008). Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index. Liver Transplantation, 14(3), 321–326.PubMedCrossRef
5.
Zurück zum Zitat Ong, S. C., Mak, B., Aung, M. O., Li, S. C., & Lim, S. G. (2008). Health-related quality of life in chronic hepatitis B patients. Hepatology, 47(4), 1108–1117.PubMedCrossRef Ong, S. C., Mak, B., Aung, M. O., Li, S. C., & Lim, S. G. (2008). Health-related quality of life in chronic hepatitis B patients. Hepatology, 47(4), 1108–1117.PubMedCrossRef
6.
Zurück zum Zitat Bondini, S., Kallman, J., Dan, A., Younoszai, Z., Ramsey, L., Nader, F., et al. (2007). Health-related quality of life in patients with chronic hepatitis B. Liver International, 27(8), 1119–1125.PubMedCrossRef Bondini, S., Kallman, J., Dan, A., Younoszai, Z., Ramsey, L., Nader, F., et al. (2007). Health-related quality of life in patients with chronic hepatitis B. Liver International, 27(8), 1119–1125.PubMedCrossRef
7.
Zurück zum Zitat Saab, S., Ibrahim, A. B., Surti, B., Durazo, F., Han, S., Yersiz, H., et al. (2008). Pretransplant variables associated with quality of life in liver transplant recipients. Liver International, 28(8), 1087–1094.PubMedCrossRef Saab, S., Ibrahim, A. B., Surti, B., Durazo, F., Han, S., Yersiz, H., et al. (2008). Pretransplant variables associated with quality of life in liver transplant recipients. Liver International, 28(8), 1087–1094.PubMedCrossRef
8.
Zurück zum Zitat EuroQol Group. (1990). EuroQol—a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef EuroQol Group. (1990). EuroQol—a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef
9.
Zurück zum Zitat Torrance, G., Feeny, D., Furlong, W., Barr, R., Zhang, Y., & Wang, Q. (1996). Multiattribute utility function for a comprehensive health status classification system: Health utilities index mark 2. Medical Care, 34(7), 702–722.PubMedCrossRef Torrance, G., Feeny, D., Furlong, W., Barr, R., Zhang, Y., & Wang, Q. (1996). Multiattribute utility function for a comprehensive health status classification system: Health utilities index mark 2. Medical Care, 34(7), 702–722.PubMedCrossRef
10.
Zurück zum Zitat Feeny, D., Furlong, W., Torrance, G., Goldsmith, C., Zhu, Z., DePauw, S., et al. (2002). Multi-attribute and single-attribute utility functions for the health utilities index mark 3 system. Medical Care, 40(2), 113–128.PubMedCrossRef Feeny, D., Furlong, W., Torrance, G., Goldsmith, C., Zhu, Z., DePauw, S., et al. (2002). Multi-attribute and single-attribute utility functions for the health utilities index mark 3 system. Medical Care, 40(2), 113–128.PubMedCrossRef
11.
Zurück zum Zitat Brazier, J., Usherwood, T., Harper, R., & Thomas, K. (1998). Deriving a preference-based single index from the UK SF-36 health survey. Journal of Clinical Epidemiology, 51(11), 1115–1128.PubMedCrossRef Brazier, J., Usherwood, T., Harper, R., & Thomas, K. (1998). Deriving a preference-based single index from the UK SF-36 health survey. Journal of Clinical Epidemiology, 51(11), 1115–1128.PubMedCrossRef
12.
Zurück zum Zitat Longworth, L., & Bryan, S. (2003). An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Economics, 12(12), 1061–1067.PubMedCrossRef Longworth, L., & Bryan, S. (2003). An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Economics, 12(12), 1061–1067.PubMedCrossRef
13.
Zurück zum Zitat Bryce, C. L., Angus, D. C., Switala, J., Roberts, M. S., & Tsevat, J. (2004). Health status versus utilities of patients with end-stage liver disease. Quality of Life Research, 13(4), 773–782.PubMedCrossRef Bryce, C. L., Angus, D. C., Switala, J., Roberts, M. S., & Tsevat, J. (2004). Health status versus utilities of patients with end-stage liver disease. Quality of Life Research, 13(4), 773–782.PubMedCrossRef
14.
Zurück zum Zitat Thein, H. H., Krahn, M., Kaldor, J. M., & Dore, G. J. (2005). Estimation of utilities for chronic hepatitis C from SF-36 scores. The American Journal of Gastroenterology, 100(3), 643–651.PubMedCrossRef Thein, H. H., Krahn, M., Kaldor, J. M., & Dore, G. J. (2005). Estimation of utilities for chronic hepatitis C from SF-36 scores. The American Journal of Gastroenterology, 100(3), 643–651.PubMedCrossRef
15.
Zurück zum Zitat Björnsson, E., Verbaan, H., Oksanen, A., Frydén, A., Johansson, J., Friberg, S., et al. (2009). Health-related quality of life in patients with different stages of liver disease induced by hepatitis C. Scandinavian Journal of Gastroenterology, 44(7), 878–887.PubMedCrossRef Björnsson, E., Verbaan, H., Oksanen, A., Frydén, A., Johansson, J., Friberg, S., et al. (2009). Health-related quality of life in patients with different stages of liver disease induced by hepatitis C. Scandinavian Journal of Gastroenterology, 44(7), 878–887.PubMedCrossRef
16.
Zurück zum Zitat Younossi, Z. M., Boparai, N., McCormick, M., Price, L. L., & Guyatt, G. (2001). Assessment of utilities and health-related quality of life in patients with chronic liver disease. The American Journal of Gastroenterology, 96(2), 579–583.PubMedCrossRef Younossi, Z. M., Boparai, N., McCormick, M., Price, L. L., & Guyatt, G. (2001). Assessment of utilities and health-related quality of life in patients with chronic liver disease. The American Journal of Gastroenterology, 96(2), 579–583.PubMedCrossRef
17.
Zurück zum Zitat Hsu, P. C., Federico, C. A., Krajden, M., Yoshida, E. M., Bremner, K. E., Anderson, F. H., et al. (2012). Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection. Journal of Gastroenterology and Hepatology, 27(1), 149–157.PubMedCrossRef Hsu, P. C., Federico, C. A., Krajden, M., Yoshida, E. M., Bremner, K. E., Anderson, F. H., et al. (2012). Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection. Journal of Gastroenterology and Hepatology, 27(1), 149–157.PubMedCrossRef
18.
Zurück zum Zitat Chong, C. A. K. Y., Gulamhussein, A., Heathcote, E. J., Lilly, L., Sherman, M., Naglie, G., et al. (2003). Health-state utilities and quality of life in hepatitis C patients. The American Journal of Gastroenterology, 98(3), 630–638.PubMedCrossRef Chong, C. A. K. Y., Gulamhussein, A., Heathcote, E. J., Lilly, L., Sherman, M., Naglie, G., et al. (2003). Health-state utilities and quality of life in hepatitis C patients. The American Journal of Gastroenterology, 98(3), 630–638.PubMedCrossRef
19.
Zurück zum Zitat Gutteling, J. J., De Man, R. A., Van Der Plas, S. M., Schalm, S. W., Busschbach, J. J. V., & Darlington, A. S. E. (2006). Determinants of quality of life in chronic liver patients. Alimentary Pharmacology & Therapeutics, 23(11), 1629–1635.CrossRef Gutteling, J. J., De Man, R. A., Van Der Plas, S. M., Schalm, S. W., Busschbach, J. J. V., & Darlington, A. S. E. (2006). Determinants of quality of life in chronic liver patients. Alimentary Pharmacology & Therapeutics, 23(11), 1629–1635.CrossRef
20.
Zurück zum Zitat Russell, R. T., Feurer, I. D., Wisawatapnimit, P., & Pinson, C. W. (2009). The validity of EQ-5D US preference weights in liver transplant candidates and recipients. Liver Transplantation, 15(1), 88–95.PubMedCrossRef Russell, R. T., Feurer, I. D., Wisawatapnimit, P., & Pinson, C. W. (2009). The validity of EQ-5D US preference weights in liver transplant candidates and recipients. Liver Transplantation, 15(1), 88–95.PubMedCrossRef
21.
Zurück zum Zitat Ratcliffe, J., Longworth, L., Young, T., Bryan, S., Burroughs, A., & Buxton, M. (2002). Assessing health-related quality of life pre- and post-liver transplantation: A prospective multicenter study. Liver Transplantation, 8(3), 263–270.PubMedCrossRef Ratcliffe, J., Longworth, L., Young, T., Bryan, S., Burroughs, A., & Buxton, M. (2002). Assessing health-related quality of life pre- and post-liver transplantation: A prospective multicenter study. Liver Transplantation, 8(3), 263–270.PubMedCrossRef
22.
Zurück zum Zitat Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271–292.PubMedCrossRef Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271–292.PubMedCrossRef
23.
Zurück zum Zitat Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004). A comparison of the EQ-5D and SF-6D across seven patient groups. Health Economics, 13(9), 873–884.PubMedCrossRef Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004). A comparison of the EQ-5D and SF-6D across seven patient groups. Health Economics, 13(9), 873–884.PubMedCrossRef
24.
Zurück zum Zitat McDonough, C. M., Grove, M. R., Tosteson, T. D., Jon, D. L., Hilibrand, A. S., & Tosteson, A. N. A. (2005). Comparison of EQ-5D, HUI, and SF-36-derived societal health state values among spine patient outcomes research trial (SPORT) Participants. Quality of Life Research, 14(5), 1321–1332.PubMedCrossRef McDonough, C. M., Grove, M. R., Tosteson, T. D., Jon, D. L., Hilibrand, A. S., & Tosteson, A. N. A. (2005). Comparison of EQ-5D, HUI, and SF-36-derived societal health state values among spine patient outcomes research trial (SPORT) Participants. Quality of Life Research, 14(5), 1321–1332.PubMedCrossRef
25.
Zurück zum Zitat Petrou, S., & Hockley, C. (2005). An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Economics, 14(11), 1169–1189.PubMedCrossRef Petrou, S., & Hockley, C. (2005). An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Economics, 14(11), 1169–1189.PubMedCrossRef
26.
Zurück zum Zitat Lamers, L. M., Bouwmans, C. A. M., Straten, Av, Donker, M. C. H., & Hakkaart, L. (2006). Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Economics, 15(11), 1229–1236.PubMedCrossRef Lamers, L. M., Bouwmans, C. A. M., Straten, Av, Donker, M. C. H., & Hakkaart, L. (2006). Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Economics, 15(11), 1229–1236.PubMedCrossRef
27.
Zurück zum Zitat Barton, G. R., Sach, T. H., Avery, A. J., Jenkinson, C., Doherty, M., Whynes, D. K., et al. (2008). A comparison of the performance of the EQ-5D and SF-6D for individuals aged ge 45 years. Health Economics, 17(7), 815–832.PubMedCrossRef Barton, G. R., Sach, T. H., Avery, A. J., Jenkinson, C., Doherty, M., Whynes, D. K., et al. (2008). A comparison of the performance of the EQ-5D and SF-6D for individuals aged ge 45 years. Health Economics, 17(7), 815–832.PubMedCrossRef
28.
Zurück zum Zitat Konerding, U., Moock, J., & Kohlmann, T. (2009). The classification systems of the EQ-5D, the HUI II and the SF-6D: What do they have in common? Quality of Life Research, 18(9), 1249–1261.PubMedCrossRef Konerding, U., Moock, J., & Kohlmann, T. (2009). The classification systems of the EQ-5D, the HUI II and the SF-6D: What do they have in common? Quality of Life Research, 18(9), 1249–1261.PubMedCrossRef
29.
Zurück zum Zitat Lam, E. T. P., Lam, C. L. K., Lai, C. L., Yuen, M. F., & Fong, D. Y. T. (2009). Psychometrics of the chronic liver disease questionnaire for southern Chinese patients with chronic hepatitis B virus infection. World Journal of Gastroenterology, 15(26), 3288–3297.PubMedCrossRef Lam, E. T. P., Lam, C. L. K., Lai, C. L., Yuen, M. F., & Fong, D. Y. T. (2009). Psychometrics of the chronic liver disease questionnaire for southern Chinese patients with chronic hepatitis B virus infection. World Journal of Gastroenterology, 15(26), 3288–3297.PubMedCrossRef
30.
Zurück zum Zitat Ware, J. E, Jr, & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.PubMedCrossRef Ware, J. E, Jr, & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.PubMedCrossRef
31.
Zurück zum Zitat Ware, J. E., Snow, K., Kosinski, J. M., & Gandek, B. (1993). SF-36 health survey manual and interpretation guide. Boston: The Health Institute, New English Medical Centre. Ware, J. E., Snow, K., Kosinski, J. M., & Gandek, B. (1993). SF-36 health survey manual and interpretation guide. Boston: The Health Institute, New English Medical Centre.
32.
Zurück zum Zitat Lam, C. L. K., Gandek, B., Ren, X. S., & Chan, M. S. (1998). Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 health survey. Journal of Clinical Epidemiology, 51(11), 1139–1147.PubMedCrossRef Lam, C. L. K., Gandek, B., Ren, X. S., & Chan, M. S. (1998). Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 health survey. Journal of Clinical Epidemiology, 51(11), 1139–1147.PubMedCrossRef
33.
Zurück zum Zitat Lam, C. L. K., Tse, E. Y. Y., & Gandek, B. (2005). Is the standard SF-12 health survey valid and equivalent for a Chinese population? Quality of Life Research, 14(2), 539–547.PubMedCrossRef Lam, C. L. K., Tse, E. Y. Y., & Gandek, B. (2005). Is the standard SF-12 health survey valid and equivalent for a Chinese population? Quality of Life Research, 14(2), 539–547.PubMedCrossRef
34.
Zurück zum Zitat Lam, C. L. K., Lauder, I., Lam, T. P., & Gandek, B. (1999). Population based norming of the Chinese (HK) version of the SF-36 health survey. Hong Kong Practitioner, 21(10), 460–470. Lam, C. L. K., Lauder, I., Lam, T. P., & Gandek, B. (1999). Population based norming of the Chinese (HK) version of the SF-36 health survey. Hong Kong Practitioner, 21(10), 460–470.
35.
Zurück zum Zitat Lam, C. L. K., Wong, C. K. H., Lam, E. T. P., Lo, Y. Y. C., & Huang, W. W. (2010). Population norm of Chinese (HK) SF-12 health survey_version 2 of Chinese adults in Hong Kong. Hong Kong Practitioner, 32, 77–86. Lam, C. L. K., Wong, C. K. H., Lam, E. T. P., Lo, Y. Y. C., & Huang, W. W. (2010). Population norm of Chinese (HK) SF-12 health survey_version 2 of Chinese adults in Hong Kong. Hong Kong Practitioner, 32, 77–86.
36.
Zurück zum Zitat McGhee, S. M., Brazier, J., Lam, C. L. K., Wong, L. C., Chau, J., Cheung, A., et al. (2011). Quality-adjusted life years: Population-specific measurement of the quality component. Hong Kong Medical Journal, 17(Suppl 6), 17–21.PubMed McGhee, S. M., Brazier, J., Lam, C. L. K., Wong, L. C., Chau, J., Cheung, A., et al. (2011). Quality-adjusted life years: Population-specific measurement of the quality component. Hong Kong Medical Journal, 17(Suppl 6), 17–21.PubMed
37.
Zurück zum Zitat Lam, C. L. K., Brazier, J., & McGhee, S. M. (2008). Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population. Value in Health, 11(2), 295–303.PubMedCrossRef Lam, C. L. K., Brazier, J., & McGhee, S. M. (2008). Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population. Value in Health, 11(2), 295–303.PubMedCrossRef
38.
Zurück zum Zitat Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33(1), 159–174.PubMedCrossRef Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33(1), 159–174.PubMedCrossRef
39.
Zurück zum Zitat Luo, N., Johnson, J. A., Shaw, J. W., & Coons, S. J. (2009). Relative efficiency of the EQ-5D, HUI2, and HUI3 index scores in measuring health burden of chronic medical conditions in a population health survey in the United States. Medical Care, 47(1), 53–60.PubMedCrossRef Luo, N., Johnson, J. A., Shaw, J. W., & Coons, S. J. (2009). Relative efficiency of the EQ-5D, HUI2, and HUI3 index scores in measuring health burden of chronic medical conditions in a population health survey in the United States. Medical Care, 47(1), 53–60.PubMedCrossRef
40.
Zurück zum Zitat Whitfield, K., Buchbinder, R., Segal, L., & Osborne, R. (2006). Parsimonious and efficient assessment of health-related quality of life in osteoarthritis research: Validation of the assessment of quality of life (AQoL) instrument. Health and Quality of Life Outcomes, 4(1), 19.PubMedCrossRef Whitfield, K., Buchbinder, R., Segal, L., & Osborne, R. (2006). Parsimonious and efficient assessment of health-related quality of life in osteoarthritis research: Validation of the assessment of quality of life (AQoL) instrument. Health and Quality of Life Outcomes, 4(1), 19.PubMedCrossRef
41.
Zurück zum Zitat Mutebi, A., Brazier, J., & Walters, S. (2011). A comparison of the discriminative and evaluative properties of the SF-36 and the SF-6D index. Quality of Life Research, 20(9), 1477–1486.PubMedCrossRef Mutebi, A., Brazier, J., & Walters, S. (2011). A comparison of the discriminative and evaluative properties of the SF-36 and the SF-6D index. Quality of Life Research, 20(9), 1477–1486.PubMedCrossRef
42.
Zurück zum Zitat Luo, N., Wang, P., Fu, A. Z., Johnson, J. A., & Coons, S. J. (2012). Preference-based SF-6D scores derived from the SF-36 and SF-12 have different discriminative power in a population health survey. Medical Care, 50(7), 627–632.PubMedCrossRef Luo, N., Wang, P., Fu, A. Z., Johnson, J. A., & Coons, S. J. (2012). Preference-based SF-6D scores derived from the SF-36 and SF-12 have different discriminative power in a population health survey. Medical Care, 50(7), 627–632.PubMedCrossRef
43.
Zurück zum Zitat Pickard, A. S., Yang, Y., & Lee, T. (2011). Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health and Quality of Life Outcomes, 9(1), 26.PubMedCrossRef Pickard, A. S., Yang, Y., & Lee, T. (2011). Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health and Quality of Life Outcomes, 9(1), 26.PubMedCrossRef
44.
Zurück zum Zitat Zhao, F. L., Yue, M., Yang, H., Wang, T., Wu, J. H., & Li, S. C. (2010). Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients. Value in Health, 13(5), 649–656.PubMedCrossRef Zhao, F. L., Yue, M., Yang, H., Wang, T., Wu, J. H., & Li, S. C. (2010). Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients. Value in Health, 13(5), 649–656.PubMedCrossRef
45.
Zurück zum Zitat Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 42(9), 851–859.PubMedCrossRef Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 42(9), 851–859.PubMedCrossRef
46.
Zurück zum Zitat Wong, C. K. H., Mulhern, B., Wan, Y. F., & Lam, C. (Under review). Responsiveness of preference-based quality of life measure was improved by mapping algorithm in colorectal cancer. Wong, C. K. H., Mulhern, B., Wan, Y. F., & Lam, C. (Under review). Responsiveness of preference-based quality of life measure was improved by mapping algorithm in colorectal cancer.
47.
Zurück zum Zitat Cheung, Y. B., Wong, L. C., Tay, M. H., Toh, C. K., Koo, W. H., Epstein, R., et al. (2004). Order effects in the assessment of quality of life in cancer patients. Quality of Life Research, 13(7), 1217–1223.PubMedCrossRef Cheung, Y. B., Wong, L. C., Tay, M. H., Toh, C. K., Koo, W. H., Epstein, R., et al. (2004). Order effects in the assessment of quality of life in cancer patients. Quality of Life Research, 13(7), 1217–1223.PubMedCrossRef
Metadaten
Titel
Comparison of direct-measured and derived short form six dimensions (SF-6D) health preference values among chronic hepatitis B patients
verfasst von
Carlos K. H. Wong
Elegance T. P. Lam
Cindy L. K. Lam
Publikationsdatum
01.12.2013
Verlag
Springer Netherlands
Erschienen in
Quality of Life Research / Ausgabe 10/2013
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-013-0403-z

Weitere Artikel der Ausgabe 10/2013

Quality of Life Research 10/2013 Zur Ausgabe